Oral lichen planus disease. Other lichen planus
Conditions
Interventions
Intervention 1: Intervention group: including 20 patients who are diagnosed with oral lichen planus patients is based on the examination of the patient by a dentist specializing in oral and dental dis
Sponsors
Ahvaz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Age 18 to 60 years Willingness to participate in the study and complete the ethical consent form Women should not be pregnant or lactating Not using allopurinol Not using viral vaccines during treatment Patients do not have a confirmed history of allergic reactions following the oral intake of methylprednisolone The patient does not have a low level of consciousness The patient should not be treated with warfarin The patient does not have an active viral disease
Exclusion criteria
Exclusion criteria: Aggravation of oral lichen lesions Unwillingness to cooperate during treatment Not using medicine for two consecutive days Emergence of allergic reaction to methylprednisolone
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Redness and inflammation. Timepoint: At the beginning of treatment and after every 2 to 10 days, the status of oral lichen planus lesions is evaluated for the severity of redness and inflammation (score 0 to 4). Method of measurement: Scoring severe redness and inflammation using a Reeda questionnaire.;Severe pain and burning. Timepoint: At the beginning of treatment and after every 2 to 10 days, the condition of oral lichen planus lesions is evaluated for the severity of pain and burning (score 0 to 4). Method of measurement: Scoring Severe pain and burning using VAS questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactJavad Kushki
Ahvaz University of Medical Sciences
Outcome results
None listed